Lifshitz Law PLLC Announces Investigation of FSTX, MBCN, RDUS, and ZEN

NEW YORK, July 09, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc (NASDAQ:FSTX ) Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of FSTX to invoX Pharma for $7.12 per share. If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com . Middlefield Banc Corp. (NASDAQ:MBCN ) Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the proposed merger of MBCN with Liberty Bancshares, Inc. Upon completion of the proposed transaction, MBCN shareholders will own approximately 69% ... Full story available on Benzinga.com